HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Optimal duration of preoperative anti-helminthic therapy for pulmonary hydatid surgery.

AbstractBACKGROUND:
The optimal duration of preoperative anti-helminths for prevention of recurrences in pulmonary hydatidosis is unclear, although 1-3 weeks of therapy is routinely used.
METHODS:
Forty-five patients of pulmonary hydatid disease were randomly assigned into four groups to receive either 0, 2, 4 or 8 weeks of preoperative albendazole (ABZ) and praziquantel (PZQ). Viability of the scolices in the fluid harvested at surgery (methylene blue staining) and ability to produce peritoneal hydatids in mice (intra-peritoneal inoculation) were compared in different groups.
RESULTS:
The percentage viability of the scolices as a whole was significantly (P < 0.001) lower in the treated cysts (n= 36, mean 43.5 +/- 35.69) compared with the untreated cysts (n= 8, mean 94.75 +/- 7.21). The viability progressively decreased with increasing durations of chemotherapy (P < 0.001). Mean percentage viability of scolices was 88.72 +/- 4.91% in patients treated for 2 weeks (n= 12), 38.09 +/- 9.10% after 4 weeks (n= 11) and 8.1 +/- 9.23% after 8 weeks (n= 14). Intra-peritoneal mice inoculation was positive in 90% of the cysts that received therapy for 2 weeks or less and none of the patients who received therapy for 8 weeks had a positive inoculation.
CONCLUSIONS:
Preoperative combination therapy with ABZ and PZQ effects a scolicidal response which increases with the increasing duration of the preoperative chemotherapy, and a 4-week course of the combination chemotherapeutic agents seems to be the minimum required duration for ensuring scolicidal activity enough to prevent spillage-induced recurrences following pulmonary hydatidosis.
AuthorsParvaiz A Koul, Anurag Ambroze Singh, Abdul G Ahanger, Abdul Wahid, Bashir A Sofi
JournalANZ journal of surgery (ANZ J Surg) Vol. 80 Issue 5 Pg. 354-7 (May 2010) ISSN: 1445-2197 [Electronic] Australia
PMID20557511 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Anthelmintics
  • Praziquantel
  • Albendazole
Topics
  • Albendazole (administration & dosage)
  • Animals
  • Anthelmintics (administration & dosage)
  • Chemotherapy, Adjuvant
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Echinococcosis, Pulmonary (diagnosis, drug therapy, surgery)
  • Humans
  • Mice
  • Praziquantel (administration & dosage)
  • Premedication

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: